Personalizing surgical therapy for patients with vulvar cancer
Vulvar cancer is uncommon and has been neglected in research and clinical trials. In recent years, researchers have learned that the most common type of vulvar cancer, vulvar squamous cell carcinoma (VSCC), develops from pre-cancerous lesions via different pathways. Currently, a "one-size-fits-all" treatment approach is used for VSCC. The aim of this study is to see if personalizing surgical therapy for patients with vulvar cancer based on HPV and TP53 status will improve outcomes.